Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala

Song Hyen Choi, Sung Jin Kim, Sang Ha Park, Bo Hyun Moon, Eunju Do, Boe Gwun Chun, Min-Soo Lee, Kyung-Ho Shin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Doxapram causes panic anxiety in humans. To determine whether doxapram alters corticotropin-releasing factor (CRF) expression in the central nucleus of the amygdala (CeA), paraventricular nucleus of hypothalamus (PVN), or bed nucleus of the stria terminalis (BNST), we used immunohistochemistry to measure CRF peptide in these brain areas after doxapram injection. Doxapram injection significantly increased CRF-like immunoreactivity (CRF-IR) within the CeA, but not in the BNST or PVN, and this increase was significant 2 h after injection. In addition, doxapram significantly increased CRF mRNA expression within the CeA, and this was most prominent 30 min after injection. These results suggest that doxapram selectively increases CRF expression within the CeA, and that this is mediated by increased CRF gene transcription. This increase in CRF-IR within the CeA might explain the doxapram-induced anxiety reaction.

Original languageEnglish
Pages (from-to)2246-2251
Number of pages6
JournalPeptides
Volume26
Issue number11
DOIs
Publication statusPublished - 2005 Nov 1

Fingerprint

Doxapram
Corticotropin-Releasing Hormone
Rats
Messenger RNA
Septal Nuclei
Injections
Paraventricular Hypothalamic Nucleus
Hypothalamus
Anxiety
Panic
Transcription
Central Amygdaloid Nucleus
Brain
Genes
Immunohistochemistry
Peptides

Keywords

  • Amygdala
  • Anxiety
  • Corticotropin-releasing factor
  • Doxapram

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Endocrinology
  • Cellular and Molecular Neuroscience

Cite this

Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala. / Choi, Song Hyen; Kim, Sung Jin; Park, Sang Ha; Moon, Bo Hyun; Do, Eunju; Chun, Boe Gwun; Lee, Min-Soo; Shin, Kyung-Ho.

In: Peptides, Vol. 26, No. 11, 01.11.2005, p. 2246-2251.

Research output: Contribution to journalArticle

Choi, Song Hyen ; Kim, Sung Jin ; Park, Sang Ha ; Moon, Bo Hyun ; Do, Eunju ; Chun, Boe Gwun ; Lee, Min-Soo ; Shin, Kyung-Ho. / Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala. In: Peptides. 2005 ; Vol. 26, No. 11. pp. 2246-2251.
@article{af518dd04585432e98ba2a12ddb97500,
title = "Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala",
abstract = "Doxapram causes panic anxiety in humans. To determine whether doxapram alters corticotropin-releasing factor (CRF) expression in the central nucleus of the amygdala (CeA), paraventricular nucleus of hypothalamus (PVN), or bed nucleus of the stria terminalis (BNST), we used immunohistochemistry to measure CRF peptide in these brain areas after doxapram injection. Doxapram injection significantly increased CRF-like immunoreactivity (CRF-IR) within the CeA, but not in the BNST or PVN, and this increase was significant 2 h after injection. In addition, doxapram significantly increased CRF mRNA expression within the CeA, and this was most prominent 30 min after injection. These results suggest that doxapram selectively increases CRF expression within the CeA, and that this is mediated by increased CRF gene transcription. This increase in CRF-IR within the CeA might explain the doxapram-induced anxiety reaction.",
keywords = "Amygdala, Anxiety, Corticotropin-releasing factor, Doxapram",
author = "Choi, {Song Hyen} and Kim, {Sung Jin} and Park, {Sang Ha} and Moon, {Bo Hyun} and Eunju Do and Chun, {Boe Gwun} and Min-Soo Lee and Kyung-Ho Shin",
year = "2005",
month = "11",
day = "1",
doi = "10.1016/j.peptides.2005.03.036",
language = "English",
volume = "26",
pages = "2246--2251",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala

AU - Choi, Song Hyen

AU - Kim, Sung Jin

AU - Park, Sang Ha

AU - Moon, Bo Hyun

AU - Do, Eunju

AU - Chun, Boe Gwun

AU - Lee, Min-Soo

AU - Shin, Kyung-Ho

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Doxapram causes panic anxiety in humans. To determine whether doxapram alters corticotropin-releasing factor (CRF) expression in the central nucleus of the amygdala (CeA), paraventricular nucleus of hypothalamus (PVN), or bed nucleus of the stria terminalis (BNST), we used immunohistochemistry to measure CRF peptide in these brain areas after doxapram injection. Doxapram injection significantly increased CRF-like immunoreactivity (CRF-IR) within the CeA, but not in the BNST or PVN, and this increase was significant 2 h after injection. In addition, doxapram significantly increased CRF mRNA expression within the CeA, and this was most prominent 30 min after injection. These results suggest that doxapram selectively increases CRF expression within the CeA, and that this is mediated by increased CRF gene transcription. This increase in CRF-IR within the CeA might explain the doxapram-induced anxiety reaction.

AB - Doxapram causes panic anxiety in humans. To determine whether doxapram alters corticotropin-releasing factor (CRF) expression in the central nucleus of the amygdala (CeA), paraventricular nucleus of hypothalamus (PVN), or bed nucleus of the stria terminalis (BNST), we used immunohistochemistry to measure CRF peptide in these brain areas after doxapram injection. Doxapram injection significantly increased CRF-like immunoreactivity (CRF-IR) within the CeA, but not in the BNST or PVN, and this increase was significant 2 h after injection. In addition, doxapram significantly increased CRF mRNA expression within the CeA, and this was most prominent 30 min after injection. These results suggest that doxapram selectively increases CRF expression within the CeA, and that this is mediated by increased CRF gene transcription. This increase in CRF-IR within the CeA might explain the doxapram-induced anxiety reaction.

KW - Amygdala

KW - Anxiety

KW - Corticotropin-releasing factor

KW - Doxapram

UR - http://www.scopus.com/inward/record.url?scp=27744538639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744538639&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2005.03.036

DO - 10.1016/j.peptides.2005.03.036

M3 - Article

C2 - 16269353

AN - SCOPUS:27744538639

VL - 26

SP - 2246

EP - 2251

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 11

ER -